4SCAR-GD2

· Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 4SCAR-GD2, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: Study on GD2 Positive Solid Tumors by 4SCAR-GD2 [Phase 1, Phase 2]